Quick answers
- What is Chlorthalidone used for?
- The FDA-approved label (Thalitone, Casper Pharma LLC, June 25, 2026) says: “THALITONE is a thiazide-like diuretic indicated: • For the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. • as adjunctive therapy in edema associated with heart failure, cirrhosis of the liver, and renal disease, including nephrotic syndrome. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Chlorthalidone have a boxed warning?
- No. None of the 77 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Chlorthalidone?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Chlorthalidone been recalled?
- FDA enforcement reports list 5 recalls of products of this medicine; the newest started September 3, 2026 (Class II). A recall usually concerns specific lots, not every product.
- Who makes Chlorthalidone?
- 38 companies list prescription products of Chlorthalidone in the FDA NDC Directory, including Bryant Ranch Prepack, A-S Medication Solutions and Northwind Health Company, LLC.
What Chlorthalidone is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
THALITONE is a thiazide-like diuretic indicated: • For the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. • as adjunctive therapy in edema associated with heart failure, cirrhosis of the liver, and renal disease, including nephrotic syndrome. …
— FDA label: Thalitone, Casper Pharma LLC, effective June 25, 2026. Read the full label on DailyMed →
The FDA has 77 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Conditions named on the label
These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.
Related medical specialties
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 77 FDA labels for this medicine have a boxed warning.
Forms and how it is given
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| chlorthalidone 12.5 mg tablet | Brand: Hemiclor | $0.9571 per tablet |
| chlorthalidone 15 mg tablet | Brand: Thalitone | $3.54 per tablet |
| chlorthalidone 25 mg tablet | Generic | $0.0731 per tablet |
| chlorthalidone 50 mg tablet | Generic | $0.1175 per tablet |
NADAC list of November 4, 2026; these prices took effect between October 21, 2026 and October 28, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Bryant Ranch Prepack19 products
- A-S Medication Solutions6 products
- Northwind Health Company, LLC5 products
- Aphena Pharma Solutions - Tennessee, LLC4 products
- Rising Pharma Holdings, Inc.4 products
- Preferred Pharmaceuticals Inc.4 products
- Dr. Reddy's Laboratories Inc.4 products
- Direct_Rx3 products
- PD-Rx Pharmaceuticals, Inc.3 products
- Remedyrepack Inc.3 products
- NorthStar Rx LLC2 products
- Unichem Pharmaceuticals (USA), Inc.2 products
- Sun Pharmaceutical Industries, Inc.2 products
- Umedica Laboratories USA Inc.2 products
- Coupler LLC2 products
- Ascend Laboratories, LLC2 products
- Zydus Pharmaceuticals USA Inc.2 products
- Nivagen Pharmaceuticals, Inc.2 products
- Proficient Rx LP2 products
- Ipca Laboratories Limited2 products
- Jubilant Cadista Pharmaceuticals Inc.2 products
- Chartwell RX, LLC2 products
- TAGI Pharma, Inc.2 products
- Lifestar Pharma LLC2 products
- Macleods Pharmaceuticals Limited2 products
- Zydus Lifesciences Limited2 products
- Major Pharmaceuticals2 products
- Ajanta Pharma USA Inc.2 products
- Amneal Pharmaceuticals LLC2 products
- Mylan Pharmaceuticals Inc.2 products
- Alembic Pharmaceuticals Limited2 products
- Alembic Pharmaceuticals Inc.2 products
- Casper Pharma LLC1 product
- Safecor Health LLC1 product
- American Health Packaging1 product
- AvPAK1 product
- Ingenus Pharmaceuticals, LLC1 product
- Mylan Institutional Inc.1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA019574 THALITONE | Casper Pharma LLC | December 20, 1988 | 13, latest September 17, 2019 2019: Labeling · 2018: Labeling · 2004: Labeling |
| NDA218647 HEMICLOR | Prm Pharma | March 17, 2025 | — |
Generic approvals (18)
- ANDA086831Mylan · February 26, 1981
- ANDA089286Sun Pharm Industries · July 21, 1986
- ANDA206904Ingenus Pharms LLC · March 30, 2017
- ANDA207222Umedica · May 24, 2018
- ANDA210742Appco · October 12, 2018
- ANDA211063Chartwell Rx · February 26, 2019
- ANDA207813Zydus Pharms · May 10, 2019
- ANDA207204Amneal Pharms Co · July 1, 2019
- ANDA211627Unichem · August 6, 2019
- ANDA213412Alkem Labs Ltd · February 11, 2020
- ANDA214129Ajanta Pharma Ltd · November 27, 2020
- ANDA211320Adaptis · February 9, 2022
- ANDA212875Pharmobedient · February 24, 2022
- ANDA212878Pharmobedient · February 24, 2022
- ANDA215587Mankind Pharma · August 4, 2022
- ANDA216262Alembic · August 26, 2022
- ANDA209162Ipca Labs Ltd · November 12, 2024
- ANDA212229Macleods Pharms · July 1, 2026
Shortage status
The FDA drug shortage list does not show these products.
Recalls
From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
September 3, 2026 · Class II · Ongoing · D-0852-2026
Failed Dissolution Specifications
Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01 — Inventia Healthcare Limited
-
June 5, 2026 · Class II · Ongoing · D-0610-2026
Failed Dissolution Specifications
Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma — Inventia Healthcare Limited
-
May 9, 2025 · Class II · Ongoing · D-0461-2025
Failed Dissolution Specifications
Chlorthalidone Tablets, USP, 25 mg, 50 Tablets (5x10) Unit Dose cards per carton, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-167-15 — AvKARE
-
February 7, 2022 · Class II · Terminated · D-0578-2022
Foreign Matter identified as stainless steel microscopic wear particles mixed with punch lubricant oil and silicone particles from the dust cup
Chlorthalidone Tablets USP 25 mg, Rx Only, 100 Tablets, Sun Pharma, Mfg. by: Fontida Bio Pharm Inc., 1100 Orthodox St. Philadephia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-6 — SUN PHARMACEUTICAL INDUSTRIES INC
-
January 26, 2022 · Class II · Terminated · D-0172-2024
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
CHLORTHALIDONE Tablets, USP, 25MG, 1000 Tablets, Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJ 08854 USA; Manufactured For: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA. NDC: 43598-719-10 — CARDINAL HEALTHCARE
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Official identifiers
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Thalitone, Casper Pharma LLC, effective June 25, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →